Benjamin Edwards Inc 10x Genomics, Inc. Transaction History

Benjamin Edwards Inc

$6.71 Billion
Q3 2024

A detailed history of Benjamin Edwards Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 58,262 shares of TXG stock, worth $790,615. This represents 0.02% of its overall portfolio holdings.

Number of Shares

58,262

Previous 314 18454.78%

Holding current value

$790,615

Previous $6,000 21816.67%

% of portfolio

0.02%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $910,363 - $1.36 Million	57,948 Added 18454.78%	58,262 $1.32 Million
Q2 2024 Aug 12, 2024	BUY	$19.45 - $37.37 $739 - $1,420	38 Added 13.77%	314 $6,000
Q1 2024 Apr 29, 2024	BUY	$36.08 - $54.3 $4,762 - $7,167	132 Added 91.67%	276 $10,000
Q4 2023 Feb 06, 2024	SELL	$34.32 - $57.55 $1,750 - $2,935	-51 Reduced 26.15%	144 $8,000
Q2 2023 Aug 15, 2023	SELL	$50.96 - $58.72 $3,363 - $3,875	-66 Reduced 25.29%	195 $11,000
Q1 2023 Apr 27, 2023	BUY	$35.33 - $55.79 $1,236 - $1,952	35 Added 15.49%	261 $15,000
Q4 2022 Feb 07, 2023	BUY	$24.4 - $41.3 $1,415 - $2,395	58 Added 34.52%	226 $8,000
Q3 2022 Oct 28, 2022	SELL	$28.48 - $52.59 $113 - $210	-4 Reduced 2.33%	168 $5,000
Q2 2022 Aug 12, 2022	BUY	$36.95 - $82.41 $332 - $741	9 Added 5.52%	172 $8,000
Q1 2022 May 04, 2022	BUY	$55.7 - $145.79 $222 - $583	4 Added 2.52%	163 $12,000
Q4 2021 Feb 07, 2022	SELL	$135.05 - $182.59 $810 - $1,095	-6 Reduced 3.64%	159 $24,000
Q3 2021 Nov 02, 2021	SELL	$145.58 - $192.14 $3,202 - $4,227	-22 Reduced 11.76%	165 $24,000
Q2 2021 Aug 11, 2021	BUY	$134.22 - $202.37 $3,758 - $5,666	28 Added 17.61%	187 $37,000
Q1 2021 May 14, 2021	BUY	$140.25 - $196.86 $22,299 - $31,300	159 New	159 $29,000

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.29B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc 10x Genomics, Inc. Transaction History